A totally new system is needed for drug research and development

E-ISSN： 1365-2362|48|2|eci.12883-eci.12883

ISSN： 0014-2972

Source： EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol.48, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development of a new delivery system consisting in ‘drug–in cyclodextrin–in PLGA nanoparticles’

By Mura Paola Maestrelli Francesca Cecchi Matteo Bragagni Marco Almeida Antonio

Journal of Microencapsulation, Vol. 27, Iss. 6, 2010-09 ,pp. : 479-486

Informa Healthcare

Access to resources Recommend Favorite

Osteoporosis: Pathophysiology and new drug development

By Vondracek Sheryl Chen Judy Csako Gyorgy

Clinical Review in Bone and Mineral Metabolism, Vol. 2, Iss. 4, 2004-12 ,pp. : 293-313

Humana Press, Inc

Access to resources Recommend Favorite

Totally drug‐resistant tuberculosis and adjunct therapies

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 4, 2015-04 ,pp. : 388-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients not patents: Drug research and development as a public enterprise

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

3. New Drug Development Group (AWO)

Oncology Research and Treatment, Vol. 21, Iss. 3, 1998-07 ,pp. : 63-64

Karger

Access to resources Recommend Favorite